- Home
- CAAP vs LNTH Comparison
CAAP vs LNTH Comparison
Compare CAAP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- LNTH
- Stock Information
- Founded
- CAAP 1998
- LNTH 1956
- Country
- CAAP Luxembourg
- LNTH United States
- Employees
- CAAP N/A
- LNTH N/A
- Industry
- CAAP Aerospace
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CAAP Consumer Discretionary
- LNTH Health Care
- Exchange
- CAAP Nasdaq
- LNTH Nasdaq
- Market Cap
- CAAP 3.1B
- LNTH 3.6B
- IPO Year
- CAAP 2018
- LNTH 2015
- Fundamental
- Price
- CAAP $18.82
- LNTH $50.84
- Analyst Decision
- CAAP Strong Buy
- LNTH Strong Buy
- Analyst Count
- CAAP 2
- LNTH 6
- Target Price
- CAAP $24.60
- LNTH $85.50
- AVG Volume (30 Days)
- CAAP 224.3K
- LNTH 1.5M
- Earning Date
- CAAP 08-20-2025
- LNTH 11-05-2025
- Dividend Yield
- CAAP N/A
- LNTH N/A
- EPS Growth
- CAAP N/A
- LNTH N/A
- EPS
- CAAP 0.93
- LNTH 3.77
- Revenue
- CAAP $1,873,095,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- CAAP $3.73
- LNTH N/A
- Revenue Next Year
- CAAP $11.19
- LNTH $3.24
- P/E Ratio
- CAAP $20.44
- LNTH $13.47
- Revenue Growth
- CAAP 26.88
- LNTH 5.75
- 52 Week Low
- CAAP $15.01
- LNTH $47.25
- 52 Week High
- CAAP $22.85
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- CAAP 37.62
- LNTH 35.30
- Support Level
- CAAP $18.82
- LNTH $51.94
- Resistance Level
- CAAP $20.47
- LNTH $55.24
- Average True Range (ATR)
- CAAP 0.67
- LNTH 1.83
- MACD
- CAAP -0.23
- LNTH 0.22
- Stochastic Oscillator
- CAAP 2.63
- LNTH 5.04
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.